Status:
UNKNOWN
Prophylactic Photodynamic Therapy to Organ Transplant Patients
Lead Sponsor:
Bispebjerg Hospital
Conditions:
Organ Transplants
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
To evaluate a possible prophylactic efficacy of photodynamic therapy on the incidence of non-melanoma skin cancer, actinic keratoses, warts and keratoses in recently organ transplanted recipients.
Eligibility Criteria
Inclusion
- Organ transplant recipients.
- Age 40 years or older.
Exclusion
- Patients younger than 40 years and older than 70 years.
- Clinical signs of skin cancer, actinic keratoses or warts at the time of inclusion.
- Previous photodynamic therapy to the skin areas investigated.
- Pregnancy or breast feeding patients.
- Patients with porphyria.
- Patients with a tendency to produce hypertrophic scars or keloids.
- Patients with known allergy to Metvix.
- Patients who are not considered able to follow the treatment protocol (e.g. severely alcoholic patients, dementia patients, mentally ill patients etc.).
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00365521
Start Date
April 1 2009
Last Update
June 2 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bispebjerg Hospital
Copenhagen, Copenhagen NV, Denmark, 2400